Latest CD4 Stories
Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission.
The HIV epidemic is continuing spread and efforts to develop a vaccine that protects against infection are still showing limited promise.
Elevated levels of p21, a protein best known as a cancer fighter, may be involved in the ability of a few individuals to control HIV infection with their immune system alone.
RICHMOND, Calif., March 3, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc.
RICHMOND, Calif., Feb. 28, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of positive preliminary clinical data from its Phase 1 trial (SB-728-902).
A new finding from scientists at the National Institutes of Health could help efforts to design vaccines and other prevention tools to block HIV in the early stages of sexual transmission, before infection takes hold. Researchers at the NIH National Institute of Allergy and Infectious Diseases have helped explain genetic differences that can distinguish some early-transmitting HIVsâ€”viruses found in an infected individual within the first month after infectionâ€”from forms of HIV...
HIV adapts in a surprising way to survive and thrive in its hiding spot within the human immune system, scientists have learned.
DURHAM, N.C., Dec. 9, 2010 /PRNewswire/ -- Argos Therapeutics announced today that its Arcelis HIV immunotherapy, AGS-004, showed feasibility in in vitro models to generate fully functional dendritic cells (DC) from viremic patients.
Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infectionâ€“namely how HIV promotes the death of CD4 T cells.
- A transitional zone between two communities containing the characteristic species of each.